| Title : Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern - Ostermann_2015_Prostaglandins.Other.Lipid.Mediat_121_131 |
| Author(s) : Ostermann AI , Herbers J , Willenberg I , Chen R , Hwang SH , Greite R , Morisseau C , Gueler F , Hammock BD , Schebb NH |
| Ref : Prostaglandins Other Lipid Mediat , 121 :131 , 2015 |
| Abstract : Ostermann_2015_Prostaglandins.Other.Lipid.Mediat_121_131 |
| ESTHER : Ostermann_2015_Prostaglandins.Other.Lipid.Mediat_121_131 |
| PubMedSearch : Ostermann_2015_Prostaglandins.Other.Lipid.Mediat_121_131 |
| PubMedID: 26117215 |
Ostermann AI, Herbers J, Willenberg I, Chen R, Hwang SH, Greite R, Morisseau C, Gueler F, Hammock BD, Schebb NH (2015)
Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern
Prostaglandins Other Lipid Mediat
121 :131
Ostermann AI, Herbers J, Willenberg I, Chen R, Hwang SH, Greite R, Morisseau C, Gueler F, Hammock BD, Schebb NH (2015)
Prostaglandins Other Lipid Mediat
121 :131